Deciphering the multifaceted significance of MPZL2 in pancreatic cancer via in-depth bioinformatics analysesCorrespondence
Life Conflux · 2024
DOI: 10.71321/75r4yp80 ↗Kurz gefasst
Fachartikel in der Zeitschrift Life Conflux, 2024. Verfasst von Ziye Zhuang und 4 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Pancreatic cancer, a deadly malignancy with a median survival of less than 1 year, urgently requires biomarkers for prognosis prediction. MPZL2, associated with poor outcomes in other cancers, was analyzed in pancreatic cancer using TCGA and GTEX data. Our study found increased MPZL2 expression in PAAD, which can distinguish patients from healthy individuals with an AUC of 0.919. High MPZL2 levels correlate with worse survival outcomes and identify malignant tumor cells as the primary source. CMap analysis suggests clofibrate may reverse MPZL2 - driven molecular changes. In conclusion, MPZL2 is a promising prognostic biomarker and therapeutic target in PAAD
Zitieren
APA
Zhuang, Z., Jiang, L., Feng, Y., Kang, Y., & Chi, H. (2024). Deciphering the multifaceted significance of MPZL2 in pancreatic cancer via in-depth bioinformatics analysesCorrespondence. Life Conflux. https://doi.org/10.71321/75r4yp80
Vancouver
Zhuang Z, Jiang L, Feng Y, Kang Y, Chi H. Deciphering the multifaceted significance of MPZL2 in pancreatic cancer via in-depth bioinformatics analysesCorrespondence. Life Conflux. 2024. doi:10.71321/75r4yp80
BibTeX
@article{Zhuang2024,
author = {Zhuang, Ziye and Jiang, Lai and Feng, Yubin and Kang, Yuan and Chi, Hao},
title = {Deciphering the multifaceted significance of MPZL2 in pancreatic cancer via in-depth bioinformatics analysesCorrespondence},
journal = {Life Conflux},
year = {2024},
doi = {10.71321/75r4yp80}
}
EUVIMED